FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Conivaptan Hydrochloride (Vaprisol) in 5% Dextrose Plastic Container
Status: Currently in Shortage
»Date first posted: 03/14/2022
»Therapeutic Categories: Cardiovascular

Cumberland Pharmaceuticals Inc. (New 03/14/2022)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/100 mL (NDC 66220-160-10) Next delivery April 2022. Estimated recovery 3Q 2022. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English